ARCHIVES

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

DCT Advisors Approve Recompetition Of Drug Discovery Groups

June 23, 1995

St. Jude Children’s Research Hospital Wins NCI Designation As Comprehensive.

May 16, 2008

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

Magnuson In Line For Appropriations Chairmanship

December 2, 1977

José Baselga Named Physician-in-Chief Of Memorial Sloan-Kettering Hospital

September 21, 2012

National Cancer Policy Forum Studies Modernization, Funding Of Cooperative Group Program.

July 11, 2008